Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Image-guided Therapy Systems Market, by Application
1.4.2 LAMEA Image-guided Therapy Systems Market, by End-Use
1.4.3 LAMEA Image-guided Therapy Systems Market, by Product
1.4.4 LAMEA Image-guided Therapy Systems Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. LAMEA Image-guided Therapy Systems Market by Application
4.1 LAMEA Cardiac Surgery Market by Country
4.2 LAMEA Urology Market by Country
4.3 LAMEA Neurosurgery Market by Country
4.4 LAMEA Gastroenterology Market by Country
4.5 LAMEA Orthopedic Surgery Market by Country
4.6 LAMEA Oncology Surgery Market by Country
4.7 LAMEA Others Market by Country
Chapter 5. LAMEA Image-guided Therapy Systems Market by End-use
5.1 LAMEA Hospitals Market by Country
5.2 LAMEA Ambulatory Surgical Centers Market by Country
5.3 LAMEA Specialty Clinics Market by Country
5.4 LAMEA Research & Academic Institutions Market by Country
Chapter 6. LAMEA Image-guided Therapy Systems Market by Product
6.1 LAMEA Endoscopes Market by Country
6.2 LAMEA Magnetic Resonance Imaging (MRI) Market by Country
6.3 LAMEA Computed Tomography (CT) Scanners Market by Country
6.4 LAMEA Ultrasound Systems Market by Country
6.5 LAMEA X-ray Fluoroscopy Market by Country
6.6 LAMEA Others Market by Country
Chapter 7. LAMEA Image-guided Therapy Systems Market by Country
7.1 Brazil Image-guided Therapy Systems Market
7.1.1 Brazil Image-guided Therapy Systems Market by Application
7.1.2 Brazil Image-guided Therapy Systems Market by End-use
7.1.3 Brazil Image-guided Therapy Systems Market by Product
7.2 Argentina Image-guided Therapy Systems Market
7.2.1 Argentina Image-guided Therapy Systems Market by Application
7.2.2 Argentina Image-guided Therapy Systems Market by End-use
7.2.3 Argentina Image-guided Therapy Systems Market by Product
7.3 UAE Image-guided Therapy Systems Market
7.3.1 UAE Image-guided Therapy Systems Market by Application
7.3.2 UAE Image-guided Therapy Systems Market by End-use
7.3.3 UAE Image-guided Therapy Systems Market by Product
7.4 Saudi Arabia Image-guided Therapy Systems Market
7.4.1 Saudi Arabia Image-guided Therapy Systems Market by Application
7.4.2 Saudi Arabia Image-guided Therapy Systems Market by End-use
7.4.3 Saudi Arabia Image-guided Therapy Systems Market by Product
7.5 South Africa Image-guided Therapy Systems Market
7.5.1 South Africa Image-guided Therapy Systems Market by Application
7.5.2 South Africa Image-guided Therapy Systems Market by End-use
7.5.3 South Africa Image-guided Therapy Systems Market by Product
7.6 Nigeria Image-guided Therapy Systems Market
7.6.1 Nigeria Image-guided Therapy Systems Market by Application
7.6.2 Nigeria Image-guided Therapy Systems Market by End-use
7.6.3 Nigeria Image-guided Therapy Systems Market by Product
7.7 Rest of LAMEA Image-guided Therapy Systems Market
7.7.1 Rest of LAMEA Image-guided Therapy Systems Market by Application
7.7.2 Rest of LAMEA Image-guided Therapy Systems Market by End-use
7.7.3 Rest of LAMEA Image-guided Therapy Systems Market by Product
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations and Agreements:
8.1.5.2 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Stryker Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 Siemens Healthineers AG (Siemens AG)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.5.3 Approvals and Trials:
8.3.6 SWOT Analysis
8.4 General Electric (GE) Co. (GE Healthcare)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.5.3 Acquisition and Mergers:
8.4.6 SWOT Analysis
8.5 Koninklijke Philips N.V.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Acquisition and Mergers:
8.6 Olympus Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.7 Analogic Corporation (Altaris Capital Partners)
8.7.1 Company Overview
8.8 Brainlab AG
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Acquisition and Mergers:
Unique Offerings 